April 12, 2022
Dirix L et al. Breast Cancer Research and Treatments, 2022
Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer
You might also be interested by
Posters
Comparable detection of large tumor-derived vesicles (oncosomes) by known CTC platforms: potential new analyte for biomarker monitoring?
April 27, 2025
More infoCase Studies & Whitepapers
Development of a personalized digital biomarker of vaccine-associated reactogenicity using wearable sensors and digital twin technology
April 21, 2025
More info